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Abstract
Objectives-(a) To test the hypothesis that a fixed 3 day course of the combination of a thiazide and loop diuretic is as effective as more prolonged treatment in the management of severe resistant cardiac failure. (b) To compare two thiazide diuretics (bendrofluazide and metolazone) in combination with loop diuretics in the treatment of severe resistant cardiac failure. Design-Randomised study with a 2 x 2 factorial design. Setting-Provincial teaching hospital. Patients-33 consecutive patients (40 episodes) admitted with severe congestive cardiac failure (New York Heart Association class III or IV) unresponsive to intravenous loop diuretics for 48 hours. Main outcome measures-Change in daily weight and serum electrolytes and clinical improvement in heart failure. Results-Diuresis was established during 37 of 40 episodes; of the rest two patients died in hospital. On 36 occasions improvement was sufficient to allow discharge from hospital. Median (range) maximal weight loss was -5 05 (-11.3 to 16) kg after the addition of bendrofluazide and -5-6 (-12.2 to 4.8) kg after the addition of metolazone (NS) . Area under the body weight loss against time curves showed no significant difference between the two thiazide diuretics. Median (range) maximal weight loss after three days of treatment was -5 4 (-12.2 to 4.8) kg and -55 (-10-3 to 1) kg after a more prolonged course of median (range) [5] [6] (1 to 13) days (NS). Area under the body weight loss time curves showed no significant difference between the two durations of treatment. Bendrofluazide was associated with fewer electrolyte disturbances. Figure 1 shows the changes in body weight after treatment with thiazide diuretics. There were no significant differences between the baseline weight of the groups. Figure 2 shows that mean serum sodium fell slightly in all groups. No significant differences were found between the fixed and variable duration groups (median area under the curve -3-5 variable, -3-75 fixed; 95% CI for the difference -9-0 to 18-5, p = 0-6). Metolazone caused a greater change in serum sodium but this was not significantly different from that caused by bendrofluazide treatment (median area under the curve metolazone -10-27, -1-75 bendrofluazide; 95% CI for the difference -19-5 to 6 p = 0-2). Potassium Figure 3 shows that serum potassium fell with thiazide treatment in all groups. There was no difference in the change in serum potassium in the variable and fixed duration groups (median area under the curve 1-0 variable, 1- Figure 4 shows that blood urea rose in all groups after treatment with thiazide. There were no significant differences between fixed or variable duration (median area under the curve 4-8 variable, 9-9 fixed; 95% CI for the difference -13-05 to 0-05, p = 0-05). Metolazone caused greater but non-significant changes in blood urea compared with bendrofluazide (median area under the curve 7-88 metolazone, 4-97 bendrofluazide; 95% CI for the difference -1-8 to 11-85, p 0-27).
Condulusions
Creatinine Figure 5 shows that serum creatinine initially fell then rose in all groups. No significant dif- Although electrolytic changes occurred they were rarely clinically significant. We expected potassium depletion to occur once diuresis was established. Therefore, we monitored for it and treated it with an oral.potassium supplement. Although hypkaaent ¶ia occurred equally commonly during fixed and variable courses of a thiazide diuretic, fewer potassium supplements were required after a fixed course. We measured changes in serum potassium only and a more accurate assessment of the change in potassium would have been obtained by measuring-total body potassium. None of these very sick patients had any complications from electrolytic changes, which were generally small.
As ACE inhibitors have been shown to prolong survival in patients with severe heart failure, all of our patients were also taking these drugs except those with contraindications or those unable to tolerate them. The groups were well matched for concomitant medication that may have influenced the diuresis. The temporary addition of a thiazide diuretic to treatment with ACE inhibitor drugs caused no specific problems.
In conclusion, in patients with severe resistant heart failure the addition of a thiazide diuretic to treatment with loop diuretics will usually establish a diuresis. Bendrofluazide apd metolazone are both-effective in this and treatment may only be necessary for 3 days.
